PRECIPIO, INC. (PRPO) Operating Margin
- Operating margin · 12 months: Value -5.58%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -5.58% | Operating income / revenue. Period ending 2026-06-30. $-1.55M ÷ $27.69M × 100 ≈ -5.58% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -1.55M USD | Operating Income (Loss) |
| Revenue | 27.69M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 15.20M USD | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | (m) | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-1.55M | $27.69M | $15.20M | (m) | (m) | -5.58% |
| 2026-03-31 | $-1.77M | $26.30M | $14.54M | (m) | (m) | -6.73% |
| 2025-12-31 | $-1.20M | $24.25M | $13.34M | $1.60M | (m) | -4.96% |
| 2025-09-30 | $-2.08M | $22.74M | $12.58M | (m) | (m) | -9.15% |
| 2025-06-30 | $-2.62M | $21.13M | $11.75M | (m) | (m) | -12.38% |
| 2025-03-31 | $-3.00M | $20.01M | $11.25M | (m) | (m) | -15.00% |
| 2024-12-31 | $-4.22M | $18.58M | $10.97M | $1.30M | (m) | -22.70% |
| 2024-09-30 | $-4.73M | $17.64M | $10.48M | (m) | (m) | -26.84% |
| 2024-06-30 | $-5.58M | $16.93M | $10.19M | (m) | (m) | -33.00% |
| 2024-03-31 | $-6.67M | $16.06M | $9.62M | (m) | (m) | -41.51% |
| 2023-12-31 | $-7.62M | $15.41M | $9.18M | $1.70M | (m) | -49.43% |
| 2023-09-30 | $-9.09M | $13.60M | $8.66M | (m) | (m) | -66.88% |
| 2023-06-30 | $-10.87M | $11.32M | $7.80M | (m) | (m) | -96.04% |
| 2023-03-31 | $-11.01M | $10.12M | $7.23M | (m) | (m) | -108.81% |
| 2022-12-31 | $-12.80M | $9.82M | $6.90M | $1.70M | (m) | -130.32% |
| 2022-09-30 | $-13.38M | $9.47M | $6.90M | (m) | (m) | -141.23% |
| 2022-06-30 | $-12.59M | $9.31M | $6.84M | (m) | (m) | -135.12% |
| 2022-03-31 | $-12.29M | $9.11M | $6.84M | (m) | (m) | -134.81% |
| 2021-12-31 | $-9.61M | $8.70M | $6.46M | $1.30M | (m) | -110.53% |
| 2021-09-30 | $-8.96M | $8.75M | $6.13M | (m) | (m) | -102.41% |
| 2021-06-30 | $-8.95M | $8.66M | $5.66M | (m) | (m) | -103.40% |
| 2021-03-31 | $-9.08M | $8.06M | $5.21M | (m) | (m) | -112.66% |
| 2020-12-31 | $-9.15M | $7.43M | $4.94M | $1.20M | $10.30M | -123.08% |
| 2020-09-30 | $-11.17M | $6.11M | $4.18M | (m) | (m) | -182.86% |
| 2020-06-30 | $-11.10M | $5.11M | $3.69M | (m) | (m) | -217.43% |
| 2020-03-31 | $-11.14M | $4.66M | $3.32M | (m) | (m) | -239.01% |
| 2019-12-31 | $-10.99M | $4.09M | $2.91M | $1.20M | $9.62M | -268.47% |
| 2019-09-30 | $-11.88M | $4.03M | $2.85M | (m) | $9.04M | -294.67% |
| 2019-06-30 | $-13.63M | $3.81M | $2.75M | (m) | $9.48M | -357.97% |
| 2019-03-31 | $-13.52M | $3.57M | $2.63M | (m) | $9.37M | -378.90% |
| 2018-12-31 | $-13.91M | $3.45M | $2.64M | $1.10M | $9.45M | -403.48% |
| 2018-09-30 | $-19.23M | $3.12M | $2.61M | (m) | $9.87M | -615.49% |
| 2018-06-30 | $-18.74M | $2.74M | $2.29M | (m) | $9.58M | -683.09% |
| 2018-03-31 | $-17.36M | (m) | $1.94M | (m) | $8.00M | (m) |
| 2017-12-31 | $-15.51M | $1.72M | $1.43M | $500.00K | $6.49M | -900.23% |
| 2017-09-30 | $-11.97M | (m) | $1.86M | (m) | $8.60M | (m) |
| 2017-06-30 | $-8.70M | (m) | $1.75M | (m) | (m) | (m) |
| 2017-03-31 | $-7.13M | $1.98M | $1.72M | $1.29M | $6.11M | -360.33% |
| 2016-12-31 | $-7.82M | $1.56M | $1.76M | $1.42M | $6.19M | -502.18% |
| 2016-09-30 | $-8.31M | $1.33M | $2.04M | $1.54M | $6.05M | -624.98% |
| 2016-06-30 | $-8.94M | $1.20M | $2.06M | $1.61M | $6.48M | -744.09% |
| 2016-03-31 | $-9.47M | $1.14M | $1.98M | $1.67M | $6.96M | -831.26% |
| 2015-12-31 | $-9.20M | $1.65M | $1.94M | $1.85M | $7.05M | -556.26% |
| 2015-09-30 | $-19.06M | $29.16M | $17.20M | $2.43M | $21.56M | -65.37% |
| 2015-06-30 | $-15.25M | $27.62M | $16.94M | $2.51M | $23.42M | -55.22% |
| 2015-03-31 | $-16.43M | $27.34M | $17.14M | $2.72M | $23.91M | -60.08% |
| 2014-12-31 | $-17.32M | $27.08M | $17.36M | $2.90M | $24.15M | -63.96% |
| 2014-09-30 | $-15.11M | $25.61M | $14.69M | $3.08M | $22.96M | -59.02% |
| 2014-06-30 | $-16.51M | $25.88M | $14.72M | $3.06M | $24.60M | -63.80% |
| 2014-03-31 | $-15.48M | $26.42M | $14.69M | $3.19M | $24.02M | -58.58% |
| 2013-12-31 | $-15.76M | $27.54M | $15.05M | $3.21M | $25.04M | -57.21% |
| 2013-09-30 | $-15.42M | $28.62M | $15.13M | $2.93M | $25.97M | -53.87% |
| 2013-06-30 | $-12.44M | $29.86M | $15.43M | $2.97M | $23.91M | -41.65% |
| 2013-03-31 | $-10.88M | $31.65M | $16.06M | $2.71M | $23.77M | -34.39% |
| 2012-12-31 | $-9.50M | $31.48M | $16.47M | $2.49M | $22.02M | -30.19% |
| 2012-09-30 | $-6.40M | $32.76M | $16.01M | $2.44M | $20.71M | -19.53% |
| 2012-06-30 | $-4.41M | $33.12M | $15.76M | $2.29M | $19.48M | -13.31% |
| 2012-03-31 | $-4.66M | $31.70M | $14.31M | $2.21M | $19.82M | -14.70% |
| 2011-12-31 | $-2.97M | $31.97M | $13.53M | $2.22M | $19.15M | -9.30% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-3.61M | $20.05M | $10.28M | $2.31M | $10.93M | -18.02% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $-1.90M | $22.02M | $10.42M | $3.18M | $10.32M | -8.61% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |